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Abstract
Background: Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diacylglycerol (DG) to produce phosphatidic
acid (PA). DGKb is widely distributed in the central nervous system, such as the olfactory bulb, cerebral cortex, striatum, and
hippocampus. Recent studies reported that the splice variant at the COOH-terminal of DGKb was related to bipolar disorder,
but its detailed mechanism is still unknown.
Methodology/Principal Findings: In the present study, we performed behavioral tests using DGKb knockout (KO) mice to
investigate the effects of DGKb deficits on psychomotor behavior. DGKb KO mice exhibited some behavioral abnor-
malities, such as hyperactivity, reduced anxiety, and reduced depression. Additionally, hyperactivity and reduced anxiety
were attenuated by the administration of the mood stabilizer, lithium, but not haloperidol, diazepam, or imipramine.
Moreover, DGKb KO mice showed impairment in Akt-glycogen synthesis kinase (GSK) 3b signaling and cortical spine
formation.
Conclusions/Significance: These findings suggest that DGKb KO mice exhibit lithium-sensitive behavioral abnormalities
that are, at least in part, due to the impairment of Akt-GSK3b signaling and cortical spine formation.
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Introduction
By activation of Gq-coupled receptors, phospholipase C (PLC) is
activated and hydrolyzes phosphoinositol 4,5-bisphosphate (PIP2)
into diacylglycerol and inositol 1,4,5-trisphosphate (IP3). Diacylgly-
cerol (DG) regulates the functions of several enzymes, such as
protein kinase C (PKC), Ras guanyl nucleotide-releasing protein,
chimerins, and transient receptor potential cation channel C 3/6
[1,2,3,4]. Subsequently, DG is phosphorylated by diacylglycerol
kinase (DGK) to produce phosphatidic acid (PA), an important lipid
second messenger which regulates several key enzymes, including
the target of rapamycin, atypical PKC and phosphatidylinositol-4-
phosphate 5-kinase (PI4P5-kinase) [1,2,3,4]. Therefore, DGK plays
animportantroleinregulating manykindsofintracellularsignaling.
DGKb, a member of the DGK family, is widely distributed in the
brain, particularly in the olfactory bulb, cerebral cortex, striatum,
and hippocampus [5]. DGKb is mainly expressed in neurons, and
its expression rapidly increases after 14 days of age in the rat, which
iscoincidentwithsynapseformationinthebrain[6].Inaddition,we
and other researchers previously demonstrated that DGKb
regulates spine formation by regulating lipids, and DGKb knockout
(KO) mice show impaired memory [7,8]. Furthermore, it was
reported that the splice variant at the COOH-terminal of DGKb
was related to bipolar disorder [9]. These results indicate that
DGKb plays an essential role in neurons, and its functions are
closely related to neurodegenerative disease and mental diseases.
Bipolar disorder is mental disorder characterized by unusual
shifts in mood from the heights of mania to the depths of
depression. The lifetime prevalence of this disease is approximately
1%, and epidemiological surveys suggested that some genes such
as Ankyrin 3 and DGKg contribute to the onset of this disorder
[10,11]. A common treatment for bipolar disorder is lithium. This
drug is comparatively effective, but it has a high incidence of
adverse effects, in particular because lithium has a narrow
therapeutic window. Therefore, new drugs which have both
efficacy and fewer side effects are needed. The purpose of our
present work was to investigate the involvement of DGKb in
bipolar disorder. For this purpose, we have developed DGKb KO
mice [8] and performed behavioral, pharmacological and
morphological tests using these mice.
Materials and Methods
Animals
DGKb KO (C57BL6/N) mice were generated using the Sleeping
Beauty transposon system as described previously [8,12,13]. This
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Pharmaceutical University (permission number; 2008-114, 2009-
038, 2009-062, and 2009-331), the Institutional Animal Care and
Use committee of Kobe University (permission number; 19-5-02)
and the committee for Safe Handling of Living Modified
organisms in Kobe University (H19-2). All procedures relating to
animal care and treatment conformed to animal care guidelines of
these committees. All efforts were made to minimize both suffering
and the number of animals used. The animals (male, 10–24 weeks
old) were housed at 2462uC under a 12 hr light-dark cycle (lights
on from 8:00 to 20:00) and had ad libitum access to food and
water. In all experiments, we used wild-type (WT) littermates as a
control group for DGKb KO mice. Behavioral experiments were
performed between 10:00 a.m. and 6:00 p.m. except for the 24 hr
home cage locomotor activity test.
Drug treatments
For an acute treatment, lithium chloride (LiCl, Wako, Osaka,
Japan) (100 and 200 mg/kg) and imipramine hydrochloride
(Wako) (20 mg/kg) were dissolved in saline; diazepam (Wako)
(1 or 3 mg/kg) was suspended in the 0.5% carboxymethylcellulose
(Wako) solution. Each drug was injected intraperitoneally (i.p.)
30 min before the test. For chronic treatment, LiCl was mixed into
the drinking water at 600 mg/L and given for 10 days [14].
Locomotor activity in the home cage
To measure locomotor activity in a novel environment, a mouse
was placed in a transparent plastic cage (length 24.56width 17.56
height 12.5 cm) withsawdust bedding on the floor. ‘‘Home cage’’ in
this draft means the same cage as they are usually housed, i.e. the
samesizeand samecolor. Animals were placed in the cages at 12:00
p.m. and left there for a 48 hr period. Locomotion was measured
every hour for 1 day after 24 hr accumulation using a digital
counter with an infrared sensor (NS-ASS01; Neuroscience, Inc.,
Tokyo, Japan). Movement of the mice was detected by the infrared
ray sensor on the basis of released infrared rays associated with their
temperature. When objects emitting an infrared ray comes across
the sensor, the sensor detected the action as locomotor counts.
Open field test
To assess the effect of a single-dose drug treatment, LiCl (100
and 200 mg/kg), haloperidol (0.1 mg/kg), diazepam (1.0 mg/kg),
or imipramine (20 mg/kg) was dissolved in saline or carboxy-
methyl cellulose, and injected intraperitoneally. After drug
treatment, each mouse was placed in the periphery of the open
field apparatus (length 306 width 306 height 30 cm). Thirty
minutes later, the total distance moved in the arena and the time
spent in the center area (length 15 6width 15 cm) were recorded
for the 1 hr test session using a computer-operated EthoVision XT
system (Noldus, Wageningen, The Netherlands). The number of
scratching behaviors was manually counted for the first 10 min of
each test session in a blind manner by a single observer (M.I.). For
assessment of chronic lithium treatment, LiCl was mixed into the
drinking water at 600 mg/L and given for 10 days. Subsequently,
each mouse was placed in the periphery of the open field
apparatus and recorded the total distance moved in the arena and
the time spent in the center area for 1 hr using EthoVision XT.
Elevated plus maze test
Elevated plus maze test apparatus consisted of two open arms
(length 30 6 width 5 cm) and two closed arms of the same size,
along with a semi-transparent wall (height 15 cm) and central
platform (length 5 6 width 5 cm). These arms and central
platform were elevated 50 cm above the floor. Each mouse was
administered diazepam (3 mg/kg, suspended in 0.5% carboxy-
methylcellulose solution) or vehicle i.p. Thirty-minutes after the
drug administration, each mouse was placed in the central
platform, facing one of the open arms. During a 10 min test
session, mouse behavior was recorded using EthoVision XT. The
number of entries into the open and closed arms, the time spent in
the open arms, and the number of times falling from the apparatus
were scored. This assessment session was conducted two times (pre
or post test) before and after the 10 days of LiCl treatment.
Forced swim test
Mice were placed in a glass cylinder (diameter 10 cm) filled with
10 cm of water (2561uC) for a period of 6 min; only for the last
5 min was immobility time measured. Each mouse was adminis-
tered imipramine hydrochloride (20 mg/kg, dissolved in saline) or
vehicle i.p. 30 min before the trial. Mice were judged to be
immobile when they remained floating passively in the water,
making only small movements to keep their heads above the water.
Tail suspension test
Each mouse was administered imipramine hydrochloride
(20 mg/kg, dissolved in saline) or vehicle i.p. Thirty min later,
mouse was tail -suspended with an adhesive tape 50 cm above the
floor, and their behavior recorded for 7 min. Immobility time was
measured for the last 6 min of the test automatically with the aid of
the EthoVision XT system. Mice were judged to be immobile
when the mobility score of the system was less than 10%.
Western blot analysis
At30 minafterLiCl(200 mg/kg,i.p.)orhaloperidol(0.1 mg/kg,
i.p.) administration, each mouse was decapitated, its brain quickly
removedfromtheskull,brieflywashedinice-coldsaline,and laid on
a cooled (4uC) metal plate where the cortex was rapidly dissected.
Brain samples were homogenized in 10 ml/g tissue ice-cold lysis
buffer [50 mM Tris-HCl (pH 8.0) containing 150 mM NaCl,
50 mM EDTA, 1% Triton X-100, and protease/phosphatase
inhibitor mixture] and centrifuged at 14,0006g for 40 min at 4uC.
An aliquot of 5 mg of protein was subjected to 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, with the separated
protein being transferred onto a polyvinylidene difluoride mem-
brane (Immobilon-P; Millipore, Billerica, MA, USA). For immu-
noblotting, the following primary antibodies were used: Anti-
phospho-Akt(Ser473) (193H12) rabbitmAb,phospho-Akt(Thr308)
(C31E5E) rabbitmAb, Aktrabbit Ab, phospho-GSK3b (Ser9) (5B3)
rabbit mAb, GSK3b (27C10) rabbit mAb, phospho-GSK3a/b
rabbit Ab, GSK3a/b rabbit Ab (1:1000 dilution; Cell Signaling,
Danvers, MA, USA), monoclonal anti-b-actin (1:5000 dilution;
Sigma Aldrich, St. Louis, MO, USA), and PHF-Tau (AT-8) mAb
(1/200 dilution, Thermo scientific, Waltham, MA, USA). The
secondary antibody was as follows: HRP-conjugated goat anti-
mouse IgG, HRP-conjugated goat anti-rabbit IgG (1:4000 dilution;
Pierce Biotechnology, Rockford, IL, USA). Immunoreactive bands
were visualized using Super Signal West Femto Maximum
Sensitivity Substrate (Thermo Scientific, Waltham, MA, USA).
The band intensity was measured using a Luminescent image
analyzer LAS-4000 UV mini (Fujifilm, Tokyo, Japan) and Multi
Gauge Ver. 3.0 (Fujifilm). For quantitative analysis, total proteins
were used as loading controls for phosphoprotein signal.
Histological staining
Mice were anesthetized with sodium pentobarbital (50 mg/kg)
and perfused with phosphate buffered saline (PBS) (pH 7.4) until the
DGKb and Bipolar Disorder
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(pH 7.4) containing 4% paraformaldehyde (Wako) for 15 min.
Brains were removed and postfixed in the same fixative for 24 hr at
4uC. For cresyl violet staining, brain sections were equilibrated in
25% sucrose solution and quickly frozen in Tissue-Tek O.C.T.
(Sakura Finetek, Torrance, CA, USA). Ten mm thick coronal
sections (Bregma + 0.5 mm) were stained with cresyl violet (Sigma,
St. Louis, MO, USA). For golgi staining, brain sections were
immersedin30%sucrosefor2to3days.Thetissueblockwasplaced
in 2% potassium dichromate for 2 days at 4uC and then in 2% silver
nitrate solution for 2 days at 4uC in the dark. The block was cut into
60 mmthickandplaced intodistilled water.Finally,thesections were
mounted onto slides,driedfor10 min,and dehydratedthrough 95%
alcohol, 100% alcohol, and clear in xylene.
Statistical analysis
Data are presented as the means 6 S.E.M. Statistical
comparisons were made by t-test or one-way ANOVA followed
by Dunnett’s test or Tukey’s test using Statview version 5.0 (SAS
Institute Inc., Cary, NC, USA), with p,0.05 being considered to
indicate a statistical significance.
Results
DGKb KO mice exhibited hyperactivity
In order to know the effects of DGKb deficit on the general
behavior and circadian rhythm in mice, we first performed
locomotor activity tests in the home cage on DGKb KO mice and
their WT littermates. In this test, the activity of DGKb KO mice
was relatively low during the light-phase, and markedly increased
just as the dark-phase began, indicating that DGKb KO mice
displayed a normal circadian rhythm (Figure 1a). However, the
total (24 hr) and dark-phase locomotor activity counts were larger
in KO mice than in WT mice (Figures 1a and b).
Next, DGKb KO mice were subjected to an open field test, and
their activity and stereotyped behavior in the novel environment
was compared. Total travel distance and the number of scratching
behaviors were significantly greater in KO mice than in WT mice
(Figures 2a–d). Moreover, administration of a mood stabilizer,
lithium revealed that the horizontal activity of lithium-treated
DGKb KO mice was decreased (Figure 2c). In comparison, this
concentration of lithium did not affect WT mice locomotor
(Figure 2c). On the other hand, other drugs, such as haloperidol
(0.1 mg/kg, i.p.), diazepam (1.0 mg/kg, i.p.), or imipramine
(20 mg/kg, i.p.), did not affect the lcomotoer activity of DGKb
KO mice (Figure S1a and d).
DGKb KO mice exhibited less anxiety
In open field test, we also assessed the anxiety level of DGKb
KO mice by measuring their stay time in the center area of open
field apparatus (anxiety-provoking area for mice). In this
assessment, DGKb KO mice spent more time in the center area
of the apparatus than WT mice (Figure 2e). To investigate the
effect of lithium on fearless behavior of DGKb KO mice, mice
Figure 1. Locomotor activity test of WT and DGKb KO mice. WT (n=10) and DGKb KO (n=9) mice were placed in individual home cages, and
their locomotion was assessed every hour for 24 hr. (a) Locomotor activity throughout the 24-hr period and (b) locomotor activity was analyzed
separately during the day and night.
*;p ,0.05,
**;p ,0.01 vs. WT mice.
doi:10.1371/journal.pone.0013447.g001
DGKb and Bipolar Disorder
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13447were given a low-dose of lithium for 10 days, and their anxiety
level in an open field test was measured. Low-dose lithium
treatment did not reduce the activity of DGKb KO mice
(Figure 2f). This paradigm of LiCl treatment produces a stable
serum Li
+ concentration [14] which is at the low end of the
therapeutic range for human patients [15]. On the other hand,
fearless behavior of lithium-treated DGKb KO mice was
significantly decreased when compared with vehicle-treated
DGKb KO mice (Figures 2g and h). No significant changes were
observed in total distance moved, duration in center zone, or
frequency to center zone between vehicle- and LiCl-treated WT
mice (Figure S2a–c), which was consistent with previous reports
[14].
To further assess anxiety levels of DGKb KO mice, we
conducted another anxiety measuring behavioral test, an elevated
plus maze test. In this test, total distance moved on the apparatus
was not different between genotypes (WT vs. KO: 13.261.1 vs.
13.762.0 m, n=7). On the other hand, the number of entries into
and the time spent in open arms of DGKb KO mice were greater
than vehicle-treated WT group, and at the same or larger levels
than anti-anxiety drug-treated WT mice (Figures 3a–d). These
results indicate that DGKb KO mice showed less anxiety. In this
test, low-dose lithium treatment also attenuated the time spent in
open arms of DGKb KO mice (Figure 3e). No significant change
was also observed in duration in open arm between vehicle- and
LiCl-treated WT mice (Figure S2d). On the other hand,
haloperidol (0.1 mg/kg, i.p.), diazepam (1.0 mg/kg, i.p.), or
imipramine (20 mg/kg, i.p.) did not affect the behavior of DGKb
KO mice in elevated plus maze test (Figure S1b, c, e, and f).
DGKb KO mice decreased immobility in forced swim test
and tail suspension test
The mouse model for mood disorders generally exhibits changes
in their depressive states, i.e. model mouse of mania exhibits lower
depressive states [14]; we evaluated these changes in DGKb KO
mice using forced swim test and tail suspension test. In each test,
both anti-depressant (imipramine)-treated WT mice and DGKb
KO mice showed a reduction in the despair state, as assessed by
immobility time in these tests (Figures 4a and b).
Figure 2. Open field test of WT and DGKb KO mice. (a–e) Assessment of the single-dose lithium effect on DGKb KO mice in the open field test.
Representative images show typical examples of WT (a) and DGKb KO (b) mice exploring behavior in the open field test. After drug treatment, each
group of mice was placed in the open field apparatus and their distance traveled (c), number of scratching behaviors (d) and time spent in the center
area (e) were measured. (n=5 to 9)
*;p ,0.05,
**;p ,0.01 vs. WT mice. (f–h) Assessment of the chronic lithium effect on DGKb KO mice in the open
field test. After 10-days of drug treatment, mice were subjected to the open field test, and distance traveled (f), time spent in the center area (g) and
the frequency of entering the center area (h) were measured for one hour. (n=6 or 7)
#;p ,0.05 vs. control mice.
doi:10.1371/journal.pone.0013447.g002
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sensorimotor gating and social interaction
To further analyze the effects of DGKb deficits on psychomotor
behavior, we evaluated schizophrenic-like behaviors in DGKb
KO mice using a prepulse inhibition (PPI) test and a social
interaction test (Method S1). In the PPI test, sensorimotor gating
can be assessed following PPI of the startle reflex, which is the
modulation of the startle response, following a weak prepulse.
Sensorimotor gating is the neural process which allows attention to
be focused on one stimulus. DGKb KO mice showed normal
responses to both startle amplitude for the pulse-only trial (Figure
S3a) and PPI (Figure S3b). In a social interaction test, we assessed
social affiliative behavior in DGKb KO mice, and the results
revealed that DGKb KO mice also exhibited normal social
interaction (Figure S3c).
Phosphorylation levels of Akt and GSK3b
Using Western blot analysis, we evaluated the phosohorylation
levels of Akt and GSK3b, which are the downstream of the
proteins PKC and PA. Moreover, these proteins were reported as
one of the pharmacological action mechanisms of lithium [16,17].
The total and phosohorylation levels of Akt and GSK3b proteins
in the hippocampus and striatum were not different between WT
mice and DGKb KO mice (data not shown). However, the
phosphorylation levels of Akt (Ser473) and GSK3b were
decreased in the cortex of DGKb KO mice despite the normal
levels of total Akt and GSK3b proteins (Figures 5a–d).
Furthermore, the treatment of lithium attenuated these reduc-
tions in the phosphorylated proteins (Figures 5a–d). The
phosphorylation level of Akt (Thr308) was also decreased in the
cortex of DGKb KO mice, compared with WT mice [WT;
Figure 3. Elevated plus maze test of WT and DGKb KO mice. Representative images show typical examples of WT (a) and DGKb KO (b) mice
exploring in the elevated plus maze apparatus. After drug treatment, each group of mice was placed in the elevated plus maze apparatus for 10 min,
and the number of entries into (c) and the time spent in open arms (d) were assessed. (e) After 10-days of drug treatment, mice were subjected to the
elevated plus maze test again, and their time spent in open arms as a ratio to the pre test was assessed. (n=7 to 9)
*;p ,0.05,
**;p ,0.01 vs. WT mice.
#;p ,0.05 vs. control mice.
doi:10.1371/journal.pone.0013447.g003
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** (n=7),
**;p ,0.01 vs. WT]. No significant change was observed
in the phosphorylation level of Akt (Ser473) or GSK3a/b between
vehicle- and LiCl-treated WT mice (Figure S4a–d). We have
additionally investigated the effect of haloperidol on the
phosphorylation levels of Akt or GSK3a/b in the cortex. In
these results, haloperidol (0.1 mg/kg, i.p.) did not alter the
decreased phosphorylation levels of Akt (Ser473), GSK3a,o r
GSK3b in DGKb KO mice (Figure S5a–e).
Morphological changes in spine formation of the cortical
neuron
To investigate the morphological factors relating to behavioral
changes and the decrease in the phoshorylation levels of Akt and
GSK3b in cortex, we first analyzed brain sections stained with
cresyl violet. In this analysis, DGKb KO mice showed normal
cortical laminar structure (Figures 6a–d). On the other hand, the
results of Golgi staining revealed that the cortical spine density of
DGKb KO mice was significantly decreased in comparison with
that of WT mice (Figures 6 e–i).
Discussion
In the present study, we performed a comprehensive behavioral
analysis of DGKb KO mice in order to investigate the role of
DGKb in higher brain functions and the relationship between
DGKb and bipolar disorder.
In the locomotor activity and open field tests, DGKb KO mice
exhibited hyperactivity in their home cage and in a novel
environment. Increased locomotor activities were observed in
other rodent models of mental disease, such as during the mania
state of bipolar disorder [18], attention deficit hyperactive disorder
(ADHD) [16], and positive symptoms of schizophrenia [19,20]. In
the open field test, LiCl at 100 mg/kg or more significantly
attenuated the hyperactivity of DGKb KO mice. It is known that
LiCl at these doses does not cause toxicity to mice [21] and, in the
present study, LiCl did not affect WT mice locomotor behavior.
On the other hand, haloperidol, diazepam, or imipramine did not
improve locomotor behaviors in DGKb KO mice. These results
indicate that the hyperactivity of DGKb KO mice is a lithium-
sensitive behavioral abnormality, similar to the mania exhibited in
some animal models. DGKb KO mice also displayed more
frequent scratching behavior than WT mice. Stereotypical
behaviors such as scratching and head twitching are induced by
the administration of psychostimulants [22], and it is also observed
in mouse model of psychiatric disorders [23].
Using an open field test or an elevated plus maze test, one is
able to evaluate anxiety levels in rodent models. In the open field
test, DGKb KO mice spent more time in the center of the
apparatus than WT mice, indicating that DGKb KO mice showed
less-anxiety. Moreover, chronic treatment with a low-dose
(600 mg/L) of lithium decreased fearless behavior in KO mice
without decreasing their locomotor activity. With this dose of LiCl
treatment, a serum concentration of Li
+ has reported to be stable
at approximately 0.41 mmol/L [14], a concentration which is
typically used to treat mania patients [15]. When the effects of the
drug on animal anxiety level are measured, a low concentration is
recommended because high concentration of LiCl causes a
decrease in mice locomotor activity. In an elevated plus maze
test, DGKb KO mice displayed enhanced open arm selectivity,
which also indicates lowered anxiety of DGKb KO mice. Chronic
LiCl treatments in DGKb KO mice also attenuated these
behavioral changes. During each session, the activity of each
group of mice was not different significantly, and therefore these
results verify that lithium specifically inhibits fearless behaviors of
DGKb KO mice in a manner not due to change in their
locomotor activity. These lithium-sensitive changes of anxiety in
mice are observed especially in the animal model of mania [14].
Forced swim test and tail suspension test are commonly used to
evaluate depression-like behaviors of rodent models. Because
existing antidepressants specifically inhibit the immobile time in
these tests, the utility of these experiments is recognized. In the
present study, DGKb KO mice exhibited antidepressant-like
behavioral changes in both tests.
In addition to the variety of behavioral changes shown above,
we previously investigated DGKb KO mice exhibiting impaired
memory [8]. The cognitive functioning of DGKb KO mice were
analyzed, and these were less affected by locomotor activity or
swimming ability [8]. Therefore, the relationship between
hyperactivity and memory impairment in DGKb KO mice is
weak. On the other hand, DGKb KO mice did not show
schizophrenia-like behavioral changes, as typified by PPI and
social interaction deficits (Figure S3). Taken together, DGKb KO
mice present lithium-sensitive excitatory psychomotor effects
related to their mood state and cognitive impairment. These
Figure 4. Antidepressant-like behaviors of DGKb KO mice. (a)
Immobile time of forced swim test. Thirty-minutes after drug treatment,
mice were placed in water for a period of 6 min; only the last 5 min
immobility time was measured. (b) Immobile time of tail suspension
test. Thirty-minutes after drug treatment, mice were tail suspended
with an adhesive tape 50 cm above the floor over a period of 7 min;
immobility time was measured in only the last 6 min. (n=7 to 9)
*;p ,0.05,
**;p ,0.01 vs. WT mice.
doi:10.1371/journal.pone.0013447.g004
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models of mania [14] and ADHD [16].
Next, to analyze the mechanisms of abnormal behavior
generation in DGKb KO mice and the lithium sensitive
mechanisms in DGKb KO mice, we assessed the phosophoryla-
tion levels of Akt and GSK3b, which lie downstream of PKC and
PA. The activity of DGK to catalyze the phosphorylation of DG
into PA is an intrinsic component of the phosphatidylinositol cycle.
Additionally, PA contributes to the activation of Akt/phosphati-
dylinositol 3-kinase (PI3K) signaling by stimulating PI4P5-kinase
[24]. Indeed, using DGKf-deficient mice, DGKf has been
reported to be involved in the PI3K/Akt pathway [25] and
phosphorylated Akt inhibits the activity of GSK3b by phosphor-
ylating at Ser9 [26,27]. It was reported that Akt and GSK3b are
one of target proteins of lithium; lithium increases the phosphor-
ylation levels of Akt and GSK3b [16,28,29,30,31]. In the present
study, the phosophorylation levels of Akt (Ser473) and GSK3b
were decreased in the cortex of DGKb KO mice. In addition,
lithium significantly attenuated the alteration of these phosophor-
ylation levels in DGKb KO mice. The phosphorylation level of
Akt (Thr308) was also decreased in the cortex of DGKb KO mice,
compared with WT mice. These decreases in levels of phosphor-
ylated Akt and GSK3b were observed in the striatum of dopamine
transporter (DAT) KO mice [16]. The effects of lithium on
phosphorylated Akt and GSK3b in DGKb KO mice are also
similar to those observed in DAT KO mice [16]. Transgenic mice
overexpressing GSK3b also display mania-like behaviors [32].
Additionally, b-catenin, the downstream protein of GSK3b over
expression mice exhibit lithium-sensitive behaviors [33]. On the
other hand, lithium attenuates the behavior of GSK3b heteroge-
neous mice in locomoter activity and tail suspension test [34]. We
have also investigated the changes of phospho-GSK3a and tau
hyperphosphorylation (using the AT8 antibody) in the cortex of
WT and DGKb KO mice. The protein level phospho-GSK3a was
decreased in DGKb KO mice compared with WT mice (Figure
S5c). On the other hand, the level of tau hyperphosphorylation in
DGKb KO mice trended to increase, but did not reach a
significant level (Figure S4e). Although we can not fully explain the
reason that the level of tau hyperphosphorylation was not
significant, it is possible that the phosphorylation of tau may be
regulated by multiple kinases. Especially, tau pshosphorylation at
Ser 202 (detected by AT8) is regulated not only by GSK3b, but
also by cyclin-dependent protein kinase 5 (cdk5) [35]. On the other
hand, GSK activity reflected the ratio of phosphor-Ser9 GSK3b to
total GSK3b levels, as others reported [36]. These results suggest
that the alteration of GSK3b function affected mood-behavior in
mice, and the lithium-sensitive excitatory mood behaviors of
DGKb KO mice are partly caused by the reduced phosphoryla-
tion levels of Akt and GSK3b. Some reports have shown that
lithium affects both Akt and GSK3 phosphorylation in the
striatum of WT animals [36]. On the other hand, in the present
study we focused solely on the cortical changes of Akt and GSK3
phosphorylation. Effects of lithium on Akt and GSK3 phosphor-
ylation may vary depending upon the brain region or the mouse
strain. Additionally, our results showing that LiCl (200 mg/kg i.p.)
did not affect locomotor activity in WT mice (Figure 2c) may
support the results of Akt and GSK3 phosphorylation in WT
cortex.
Previously, we and other groups have reported the contribution
of DGKb to hippocampal spine formation [7,8]. Our present
study revealed that impaired spine formation also occurred in the
cortex of DGKb KO mice without changing cortical laminar
structure. The decrease of spine density in cortex was observed in
many animal models expressing abnormal psychomotor behaviors
[20,37,38]. In addition, postmortem brain analysis revealed that
spine density on the primary apical dendrites of the cortex layer III
Figure 5. Western blot analysis of Akt-GSK3b signaling. (a, b) Phosphorylated Akt (Ser473) and GSK3b were decreased in the cortex of control
group of DGKb KO mice. (c, d) Quantitative analysis of Western blotting showed that phosphorylated Akt (Ser473) and GSK3b were decreased in the
cortex of DGKb KO mice, and that lithium treatment attenuated this effect. (n=7)
*;p ,0.05,
**;p ,0.01 vs. WT mice.
#;p ,0.05,
##;p ,0.01 vs. control
mice.
doi:10.1371/journal.pone.0013447.g005
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patients [39,40]. As the reports implied, dendrite spine dysplasia
led to the expression of abnormal behavior, and in DGKb KO
mice the decrease of cortical spine density, in turn, may have led to
the observed abnormalities in behavior.
In conclusion, DGKb KO mice exhibited lithium-sensitive
excitatory psychomotor behaviors related to their mood state. The
phenotypes of DGKb KO mice may be caused, at least in part, by
the impairment of Akt-GSK3b signaling and cortical spine
dysplasia.
Supporting Information
Method S1 Prepulse inhibition and social interaction test.
Found at: doi:10.1371/journal.pone.0013447.s001 (0.03 MB
DOC)
Figure 6. Histological analysis of the cortex in DGKb KO mice. (a–d) Cresyl violet staining. (a, b) Representative photomicrographs show
coronal sections stained with cresyl violet. (c, d) DGKb KO mice showed no defects in the layered structure of the cerebral cortex. Scale bar =100 mm
(e–i) Golgi staining. (e, f) Representative photomicrographs show pyramidal neurons in the cortex stained by Golgi. Scale bar =100 mm (g, h)
Representative photomicrographs show high-magnification images of apical dendritic segments. Scale bar =5 mm (i) Quantitative analysis of spine
density in WT mice and DGKb KO mice. (n=11 or 15)
**;p ,0.01 vs.WT mice.
doi:10.1371/journal.pone.0013447.g006
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PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13447Figure S1 Effects of haloperidol, imipramine, and diazepam in
open field test and elevated plus maze test. Haloperidol (0.1 mg/
kg, i.p.), diazepam (1.0 mg/kg, i.p.), imipramine (20 mg/kg, i.p.),
or vehicle was administrated at 30 min before the behavioral trial.
(a–c) The effects of haloperidol (0.1 mg/kg, i.p.) in open field test
and elevated plus maze test. (a) Distance moved was measured in
open field test (n=8 to10). (b) Time spent in and (c) frequency to
open arms were measured in elevated plus maze test (n=7 to 9).
Veh; vehicle, Hal; haloperidol, *; p,0.05 vs. vehicle-treated WT
mice. (d–f) The effects of diazepam (1.0 mg/kg, i.p.) and
imipramine (20 mg/kg, i.p.) in open field test and elevated plus
maze test. (d) Distance moved was measured in open field test
(n=6 or 7). (e) Time spent in and (f) frequency to open arms were
measured in elevated plus maze test (n=5 to 12). Imi; imipramine,
Dia; diazepam, *; p,0.05, **; p,0.01 vs. vehicle-treated WT
mice.
Found at: doi:10.1371/journal.pone.0013447.s002 (4.21 MB TIF)
Figure S2 Effects of chronic LiCl administration on the
behavior of WT mice. For assessment of chronic lithium
treatment, LiCl was mixed into the drinking water at 600 mg/L
and given for 10 days. Controls were given normal water. After the
10-days drug treatment, WT mice were subjected to the open field
test and elevated plus maze test. (a) Distance moved, (b) duration
in, and (c) frequency into center zone were measured in open field
test (n=12 and 13). (d) Time spent in open arms, as a ratio to the
pre test, in elevated plus maze test (n=11).
Found at: doi:10.1371/journal.pone.0013447.s003 (3.84 MB TIF)
Figure S3 Prepulse inhibition and social interaction test in
DGKb KO mice. (a, b) PPI of acoustic startle response in WT
(n=7) and KO mice (n=9). (a) In the 120 dB-pulse-only trials,
startle amplitude did not differ significantly between DGKb KO
and WT mice. (b) The PPI is expressed as a percentage of the
startle response to a 120 dB-pulse. DGKb KO mice showed
normal PPI at each prepulse intensity. (c) Social interaction test in
a novel environment in WT (n=8) and KO (n=8) mice. Two
genetically identical mice that had been housed separately were
placed in the same cage. Their social interaction was then
monitored for 10 min. There was no significant difference in
duration per contact between WT and DGKb KO mice.
Found at: doi:10.1371/journal.pone.0013447.s004 (1.03 MB TIF)
Figure S4 Western blot analysis in Akt-GSK3b signaling. Effects
of LiCl on Akt-GSK3b signaling in the cortex of WT mice were
measured (a–e). LiCl (200 mg/kg, i.p.) or vehicle was adminis-
trated at 30 min before the western blotting. (a) Representative
images of immunoblottin showing p-GSK3a/b, total GSK3a/b,
p-Akt (Ser473), total Akt, and b-actin. Quantitative analysis of (b)
p-GSK3a/GSK3a, (c) p-GSK3b/GSK3b, and (d) p-Akt
(Ser473)/Akt (n=7). (e) Tau phosphorylation (using the AT8
antibody) in the cortex of WT and DGKb KO mice (n=5 and 6).
Found at: doi:10.1371/journal.pone.0013447.s005 (3.61 MB TIF)
Figure S5 Effects of haloperidol on Akt-GSK3b signaling in the
cortex of WT and DGKb KO mice. Haloperidol (0.1 mg/kg, i.p.)
or vehicle was administrated at 30 min before the western blotting.
Representative images of immunoblottin showing (a) p-GSK3a/b
and total GSK3a/b, and (b) p-Akt (Ser473) and total Akt.
Quantitative analysis of (c) p-GSK3a/GSK3a, (d) p-GSK3b/
GSK3b, and (e) p-Akt (Ser473)/Akt. (n=5 and 8). Veh; vehicle,
Hal; haloperidol, *; p,0.05, **; p,0.01 vs. vehicle-treated WT
mice.
Found at: doi:10.1371/journal.pone.0013447.s006 (4.03 MB TIF)
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